[LXRX] QoQ Quarter Result on 31-Dec-2018 [#Q4]

Stock
[LXRX] Lexicon Pharmaceuticals, Inc.
Announcement Date
14-Mar-2019
Financial Year
2018
Quarter
31-Dec-2018 [#Q4]
Profit Trend
QoQ- 39.00%
YoY- 40.87%
Quarter Report
LXRX's Result
LXRX's Financial Summary
View:
Show?
Quarter Result
30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 CAGR
Revenue 294,448 9,682 9,216 17,071 6,856 13,753 25,207 414.05%
PBT 220,072 -23,018 -21,797 -16,781 -27,512 -34,706 -42,075 -
Tax -6,014 -219 789 -102 783 6,097 6,119 -
NP 226,086 -23,018 -21,797 -16,781 -27,512 -34,706 -42,075 -
Tax Rate 2.73% - - - - - - -
Total Cost 68,362 32,700 31,013 33,852 34,368 48,459 67,282 1.06%
Ratio Analysis
30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 CAGR
NP Margin 76.78 -237.74 -236.51 -98.30 -401.28 -252.35 -166.92 -
Per Share
30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 CAGR
EPS 2.13 -0.22 -0.21 -0.16 -0.26 -0.33 -0.40 -
EPS Diluted 1.95 -0.22 -0.21 -0.16 -0.26 -0.33 -0.40 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.